What is the starting dose for a norepinephrine (norepinephrine) drip in treating hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Starting Dose for Hypotension

Start norepinephrine at 0.02 mcg/kg/min (approximately 8-12 mcg/min or 0.5 mg/h in a 70 kg adult), administered as a continuous IV infusion, preferably through central venous access, while simultaneously ensuring adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus. 1, 2, 3

Initial Dosing Parameters

The FDA-approved starting regimen involves diluting 4 mg of norepinephrine in 1000 mL of 5% dextrose solution (yielding 4 mcg/mL concentration), then initiating at 2-3 mL/min (8-12 mcg/min) and titrating to effect. 3 Alternative weight-based dosing recommendations range from 0.02 mcg/kg/min 1 to 0.1-0.5 mcg/kg/min 2, 4, with the lower end being more appropriate for initial therapy.

Standard Concentration Preparation

  • Add 4 mg norepinephrine to 250 mL D5W to create 16 mcg/mL concentration 2
  • Alternatively, use the FDA standard of 4 mg in 1000 mL D5W for 4 mcg/mL concentration 3
  • Never dilute in saline alone - dextrose-containing solutions are essential to prevent oxidation and loss of potency 3

Critical Pre-Administration Requirements

Address hypovolemia FIRST with a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation. 2, 4 This is a strong recommendation with moderate quality evidence from the Surviving Sepsis Campaign. 2 The only exception is profound, life-threatening hypotension (systolic <70 mmHg) where norepinephrine should be started emergently while fluid resuscitation continues simultaneously. 2

Fluid Resuscitation Specifics

  • Use balanced crystalloids (lactated Ringer's, Plasma-Lyte) preferentially over normal saline 1
  • In pregnant patients with sepsis, consider more restrictive initial boluses (1-2 L) due to lower colloid oncotic pressure and higher pulmonary edema risk 1
  • Never use hydroxyethyl starch (HES) - it increases mortality (51% vs 43%, p=0.03) and causes renal injury 2

Administration Route and Monitoring

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 2, 4, 3 However, if central access is unavailable or delayed, peripheral IV administration can be used temporarily with strict monitoring. 1, 2

Monitoring Protocol

  • Place arterial catheter as soon as practical for continuous blood pressure monitoring 2, 4
  • Check blood pressure every 5-15 minutes during initial titration 2
  • Monitor tissue perfusion markers: lactate clearance, urine output (goal >50 mL/h), mental status, capillary refill 2

Target Blood Pressure and Titration

Target mean arterial pressure (MAP) of 65 mmHg is the standard goal for septic shock. 1, 2, 4 In previously hypertensive patients, avoid raising systolic BP more than 40 mmHg below their baseline. 3 Patients with chronic hypertension or atherosclerosis may require higher MAP targets. 2

Titration Strategy

  • Increase by 0.5 mg/h every 4 hours as needed 2
  • Typical maintenance range: 2-4 mcg/min (0.5-1 mL/min of standard dilution) 3
  • Maximum doses can reach 68 mg/day in refractory cases, though occult hypovolemia should always be suspected at high doses 3

Escalation for Refractory Hypotension

When norepinephrine reaches 0.1-0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min as second-line therapy rather than continuing to escalate norepinephrine alone. 1, 2 This approach is supported by the Surviving Sepsis Campaign guidelines. 2

Additional Vasopressor Options

  • Epinephrine 0.1-0.5 mcg/kg/min can be added if vasopressin is insufficient 2
  • Avoid dopamine - it is associated with higher mortality and arrhythmias compared to norepinephrine 2
  • Phenylephrine is NOT recommended except in specific circumstances (e.g., norepinephrine causing serious arrhythmias) 2

Special Populations

Obese Patients

  • Require lower weight-based doses (0.09 vs 0.13 mcg/kg/min) but similar absolute doses compared to non-obese patients 5
  • Consider using non-weight-based dosing (8-12 mcg/min starting dose) to avoid underdosing 5

Pregnant Patients

  • Start at 0.02 mcg/kg/min with target MAP 65 mmHg 1
  • Consider adding vasopressin 0.04 units/min for refractory shock, with fetal monitoring when appropriate 1
  • Theoretical oxytocin receptor interaction with vasopressin is not a contraindication 1

Critical Pitfalls to Avoid

  • Never start norepinephrine without addressing hypovolemia - vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 2
  • Do not mix with sodium bicarbonate or alkaline solutions - adrenergic agents are inactivated in alkaline solutions 2, 3
  • If extravasation occurs, immediately infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the site to prevent tissue necrosis 2, 4, 3
  • Avoid excessive fluid resuscitation - early norepinephrine administration can prevent fluid overload while maintaining perfusion 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2016

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.